TY - JOUR T1 - Extension of Community Healthcare Outcomes in Parkinson Disease (Parkinson ECHO): A Feasibility Study JF - medRxiv DO - 10.1101/2022.01.31.22270212 SP - 2022.01.31.22270212 AU - Lee E. Neilson AU - Jennifer Wilhelm AU - Margaret McLain McDonnell AU - Lisa Mann AU - Jeff A. Kraakevik Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/02/01/2022.01.31.22270212.abstract N2 - Parkinson’s disease is the second most common neurodegenerative disorder and presents with a heterogeneous group of symptoms. Managing these symptoms requires coordinated care from a neurology specialist and a primary care provider. Access to neurology care is limited for those patients with Parkinson’s disease who reside in rural areas given financial and mobility constraints along with the rarity of specialty providers. To close this gap, we developed and implemented a telehealth-based Project ECHO® (Extension for Community Healthcare Outcomes) program, “Parkinson ECHO,” to provide education and support for rural clinicians and allied health members. We assessed the feasibility of this tele-mentoring educational offering and the effect it had on clinician confidence in diagnosing and treating Parkinson’s disease. Participants from across Oregon (n=33), of whom 70% served rural and/or medically underserved communities, attended the biweekly sessions. The sessions focused on a topic within Parkinson’s disease diagnosis or management followed by case discussions. We assessed clinician confidence and acceptability using surveys before and after their participation in the program. The COVID-19 pandemic was an unexpected obstacle in executing this project, delaying the program by several months and likely accounting for a lower number of attendees for the last two sessions. Nevertheless, we found Parkinson ECHO did significantly increase participant confidence levels in diagnosing and managing Parkinson’s disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFinancial support of this work was provided by the Parkinson Foundation through a community grant and by the Oregon ECHO Network. Writing of this manuscript was supported by the Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veteran Affairs as well as the Northwest Parkinson Disease Research, Education, and Clinical Center (PADRECC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This was submitted to the Institutional Review Board at OHSU as Study #00020683. They determined that the proposed activity is not research involving human subjects and that IRB review and approval was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher. ER -